A Phase IV Open-labelled, Single-centered, Stratified-randomized Clinical Trial in Zhejiang Province to Evaluate the Safety and Immunogenicity of EV71 Vaccine Developed by Sinovac Biotech Co., Ltd.
Phase of Trial: Phase IV
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Enterovirus A infections
- Focus Pharmacodynamics
- Sponsors Sinovac Biotech
- 28 Dec 2018 Status changed from recruiting to completed.
- 14 Sep 2017 New trial record